Genetic alterations in early-onset invasive breast carcinomas: Correlation of c-erbb-2 amplification detected by fluorescence in situ hybridization with p53 accumulation and tumor phenotype

International Journal of Cancer

Volumn 84, Issue 5, 1999, Pages 511-515

  Fiche, Maryse ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEIN P53;

ADULT; ARTICLE; BREAST TUMOR; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENETICS; HUMAN; MIDDLE AGED; PHENOTYPE; PROTO ONCOGENE;

ADULT; BREAST NEOPLASMS; FEMALE; GENE AMPLIFICATION; GENES, ERBB-2; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; PHENOTYPE; RECEPTOR, ERBB-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033595614     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(19991022)84:5<511::aid-ijc11>3.0.co;2-5     Document Type: Article

References (20)

1. ALBAIN, K.S., ALLRED, D.C. and CLARK, G.M., Breast cancer outcome and predictors of outcome: are there age differentials? J. nat. Cancer Inst. Monogr., 16, 35-42(1994).
2. BERTHEAU, P., STEINBERG, S.M. and MERINO, M.J., c-erbB-2, p53, and nm23 gene product expression in breast cancer in young women: immunohistochemical analysis and clinicopathologic correlation. Hum. Pathol., 29, 323-329 (1998).
3. CHUNO, M., CHANO, H.R., BLAND, K.I. and WANEBO, H.J., Younger women with breast carcinoma have a poorer prognosis than older women. Cancer, 77, 97-103(1996).
4. CLAUS, E.B., Genetic epidemiology of breast cancer in younger women. J. not. Cancer Inst. Monogr., 16, 49-53 (1994).
5. DE LA ROCHEFORDIÈRE, A., ASSELAIN, B., CAMPANA, F., SCHOLL, S.M., FENTON, J., VILCOQ, J.R., DURAND, J.C., POUILLART, P., MAGDELENAT, H. and FOURQUET, A., Age as a prognostic factor in premenopausal breast carcinoma. Lancet, 341, 1039-1043 (1993).
6. ELSTON, C.W. and ELLIS, I.O., Pathological prognosis facrors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology, 19, 403-410 (1991).
7. EYFJORD, J.E., THORLACIUS, S., VALGARDSDOTTIR, R., STEINARSDOTTIR, R. and OGMUNDSDOTTIR, H.M., p53 abnormalities and genomic instability in primary human breast carcinomas. Cancer Res., 55, 646-651 (1995).
8. FISHER, C.J., EGAN, M.K., WICKS, K., MILLIS, R.R. and FENTIMAN, I.S., Histopathology of breast cancer in relation to age. Brit. J. Cancer, 75, 593-596(1997).
9. GUSTERSON, B.A., GELBER, R.D., GOKDHIRSCH, A. ET AL., Prognostic importance of c-erb B-2 expression in breast cancer. 7. din Oncol., 10, 1049-1056(1992).
10. HOLLI, K. and ISOLA, J., Effect of age on the survival of breast cancer patients. Europ. J. Cancer, 33, 425-428 (1997).
11. KRAINER, M., SILVA-ARRIETA, S., FITZGERALD, M., SHIMADA, A., SHIOKA, C., KANAMARU, R., MACUONALD, D., UNSAL, H., FINKELSTEIN, D., BOWCOCK, A., ISSELBACHER, K. and HABER, D.A., Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer. Ne\v Engl. J. Med., 336, 1416-1421 (1997).
12. LIZARD-NACOL, S., RIEDLNGER, J.M., LIZARD, G., CLASSER, A.L., COUDRAY, N., CHAPLAIN, G. and GUERRIN, J., Loss of heterozygosity at the TP53 gene: independent occurrence from genetic instability events in node-negative breast cancer. Int. J. Cancer, 72, 599-603 (1997).
13. MARCUS, J.N., WATSON, P., PAGE, D.L. and LYNCH, H.T., Pathology and heredity of breast cancer in younger women. J. nat. Cancer Inst. Monogr., 16, 23-34(1994).
14. PRESS, M.F. and 14 OTHERS, HER-2/neii gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. J. din. Oncol, 15, 2894-2904 (1997).
15. REMVIKOS, Y., MAGDELENAT, H. and DUTRILLAUX, B., Genetic evolution of breast cancers. III. Age-dependent variations in the correlations between biological indicators of prognosis. Breast Cancer Res. Treat., 34, 25-33 (1995).
16. Ross, J.S. and FLETCHER, J.A., The HER-2/neii oncogene in breast cancer: prognostic factor, predictive factor and target for therapy. Stem Cells, 16, 413-428(1998).
17. SESHADRI, R., LEONG, A.S., McCAUL, K., FIRGAIRA, F.A., SETLUR, V. and HORSFALL, D.J., Relationship between p53 gene abnormalities and other tumour characteristics in breast-cancer prognosis. Int. J. Cancer, 69, 135-141 (1996).
18. SLAMON, D.J., GODOLPHIN, W., JONES, L.A., HOLT, J.A., WONG, S.G., KEITH, D.E., LEVIN, W.J., STUART, S.G., UDOVE, J., ULLRICH, A. and PRESS, M.F., Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science, 244, 707-712 (1989).
19. WALKER, R., LEES, E., WEBB, M. and DEARING, S., Breast carcinomas occurring in young woman-(<35) are different. Brit. J. Cancer, 74, 1796-1800(1996).
20. XING, W.R., GILCHRIST, K.W., HARRIS, C.P., SAMSON, W. and MEISNER, L.F., FISH detection of HER-2/neu oncogene amplification in early onset breast cancer. Breast Cancer Res. Treat., 39, 203-212 (1996).